People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aura Biosciences, Inc. | — | Biotechnology | Series C | $198.2M | $2.5B | 2010 |
| 4Tech, Inc. | — | Biotechnology | Series B | $62.3M | $1.1B | 2011 |
| Neosync Inc | — | Healthtech | Series A | $12.4M | $203.2M | 2010 |
| Myriad Genetics Inc | — | Biotechnology | Pre-Seed | $249K | $13.8M | 2019 |
Lawrence C. Best at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lawrence C. Best on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Johnson | 1 | 35 |
| Peter B. Finn | 1 | 11 |
| Casper Breum | 1 | 5 |
| Benjamin Tsai | 1 | 4 |
| Pedro Granadillo | 1 | 3 |
| Rudi Marien | 1 | 3 |
| Jan Pensaert | 1 | 3 |
| Peter Wirth | 1 | 3 |
| Javier Garcia | 1 | 3 |
| Art Pappas | 1 | 3 |
| Alan Walts | 1 | 3 |
| Henri E. Termeer | 1 | 2 |
| Karan Takhar | 1 | 2 |
| Mark E. Chin | 1 | 2 |
| Dennis C. Langer | 1 | 2 |
| Benjamin C. Tsai | 1 | 2 |
| Christian Schetter | 1 | 2 |
| Edmundo Muniz, M.D., Ph.D. | 1 | 2 |
| Casper E. Breum | 1 | 2 |
| Israel B. Ruiz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.